Vanguard Global Advisers
TMDX icon

Vanguard Global Advisers’s Transmedics TMDX Stock Holding History

Vanguard Global Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$891K Sell
13,421
-1,174
-8% -$99.4K ﹤0.01% 1815
2026
Q1 		$1.45M Buy
+14,595
New +$1.9M ﹤0.01% 1408

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Global Advisers's TMDX Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Transmedics (TMDX) stake by 8% in Q2 2026, selling an estimated $99.4K and leaving 13,421 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Vanguard Global Advisers first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.45M in Q1 2026. 370 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Vanguard Global Advisers held 13,421 shares of Transmedics worth $891K as of Q2 2026.
  • Vanguard Global Advisers sold 1,174 Transmedics shares in Q2 2026, an estimated $99.4K.
  • Transmedics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1815 holding.
  • Vanguard Global Advisers first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Transmedics position peaked at $1.45M in Q1 2026.
  • 370 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.